2. Inflammation/Immunology

Inflammation/Immunology

Inflammation/Immunology

Related Products

PDF 93.1 MB

The diseases caused by disorders of the immune system fall into two broad categories: immunodeficiency and autoimmunity. Immunotherapy is also often used in the immunosuppressed (such as HIV patients) and people suffering from other immune deficiencies or autoimmune diseases. This includes regulating factors such as IL-2, IL-10, IFN-α. Infection with HIV is characterized not only by development of profound immunodeficiency but also by sustained inflammation and immune activation. Chronic inflammation as a critical driver of immune dysfunction, premature appearance of aging-related diseases, and immune deficiency.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-P990759
    Rezetamig 2795115-07-8 98%
    Rezetamig is an anti-CD3E/CD22 monoclonal antibody.
    Rezetamig
  • HY-P990763
    Sifarobocept 2760175-31-1 98%
    Sifarobocept is a recombinant fusion protein comprising an roundabout guidance receptor 2 (ROBO2) fused to a human IgG1 Fc.
    Sifarobocept
  • HY-P990780
    Zeleciment 2725863-34-1 98.85%
    Zeleciment is an anti-TFRC IgG1κ monoclonal antibody.
    Zeleciment
  • HY-P990902
    Atigotatug 2733581-82-1 98%
    HY-P990902 is an Fucosyl ganglioside GM1-targeting IgG1κ type humanized antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Atigotatug
  • HY-P990913
    Dalmitamig 2765077-69-6 98%
    HY-P990913 is an EGFR/CD28-targeting IgG4κ type human antibody, the recommed isotype control is Human IgG4 (S228P) kappa, Isotype Control (HY-P99003).
    Dalmitamig
  • HY-P990929
    Misitatug 2767203-01-8 99.00%
    HY-P990929 is an MSLN-targeting IgG1κ type chimeric antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Misitatug
  • HY-P990932
    Obrixtamig 2851943-09-2 98%
    HY-P990932 is an CD3E/DLL3-targeting L-κ-G1-h-CH2-CH3_L-λ-G1-h-CH2-CH3 type human antibodychimeric antibody.
    Obrixtamig
  • HY-P990947
    Tilatamig 2868265-50-1 98%
    HY-P990947 is an EGFR/MET-targeting Ig(G1 -κ_G1 -λ2) type human antibody.
    Tilatamig
  • HY-P990948
    Trosunilimab 2550297-60-2 98%
    HY-P990948 is an ITGA4_ITGB7-targeting IgG1κ type chimeric humanized antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Trosunilimab
  • HY-P990995
    Etalanetug 2690265-18-8 98%
    HY-P990995 is an MAPT-targeting IgG1κ type humanized antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Etalanetug
  • HY-P991034
    Trevotamig 2920215-79-6 98%
    HY-P991034 is an EPCAM/CD3E-targeting H-γ1_L-κ-scFvhl dimer type bispecific antibody.
    Trevotamig
  • HY-P991050
    Procizumab 98%
    Procizumab (AK-1967) is a humanized IgG1 antibody that targets dipeptidyl peptidase 3 (DPP3). Procizumab has the potential for the study of sepsis. The isotype control for Procizumab can refer to Human IgG1 kappa, Isotype Control (HY-P99001).
    Procizumab
  • HY-P991051
    GSK-2330811 98%
    GSK-2330811 is a humanized IgG1 antibody that targets Oncostatin M (OSM). GSK-2330811 has the potential for the study of diffuse cutaneous systemic sclerosis (dcSSc). The isotype control for GSK-2330811 can refer to Human IgG1 kappa, Isotype Control (HY-P99001).
    GSK-2330811
  • HY-P991055
    Forimtamig 2649379-96-2 98%
    Forimtamig (RG-6324) is a GPRC5DxCD3 T-cell-engaging bispecific antibody. Forimtamig has a 2 + 1 format, comprising two high-affinity GPRC5D binding moieties and one CD3 binder. Forimtamig further features a P329G LALA mutated Fc domain that inhibits Fcγ receptor and C1q binding, yet retains binding to the neonatal Fc receptor. The isotype control for Forimtamig can refer to Human IgG1 kappa, Isotype Control (HY-P99001).
    Forimtamig
  • HY-P991083
    MAS825 98%
    MAS825 is a bispecific IL-1β and IL-18 monoclonal antibody that reduces inflammasome-mediated inflammation. MAS825 combines the anti-IL-1β and anti-IL-18 monoclonal antibodies (mAbs) inhibition domains in a single bispecific high-affinity cytokine capture molecule.
    MAS825
  • HY-P991103
    Anti-IL-25 Antibody 99.60%
    Anti-IL-25 Antibody is a human antibody expressed in CHO cells, targeting IL-25. Anti-IL-25 Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
    Anti-IL-25 Antibody
  • HY-P991110
    Anti-Mouse CD25 Antibody (7D4) 98%
    Anti-Mouse CD25 Antibody (7D4) is a mouse IgG2 monoclonal antibody that targets CD25. Recommend Isotype Controls: Mouse IgG2a kappa, Isotype Control (HY-P99978).
    Anti-Mouse CD25 Antibody (7D4)
  • HY-P991112
    Anti-Mouse CD8α Antibody (YTS169.4) 98%
    Anti-Mouse CD8α Antibody (YTS169.4) is an IgG2 monoclonal antibody that targets CD8α. Recommend Isotype Controls: Rat IgG2b kappa, Isotype Control (HY-P990682).
    Anti-Mouse CD8α Antibody (YTS169.4)
  • HY-P991122
    Besufetamig 3037124-22-1 98%
    Besufetamig is a bispecific antibody targeting programmed cell death 1 (PD-1) and CD3ε chain. Besufetamig modulates the activity of immune cells, exerting immunosuppressive and antineoplastic activities. Besufetamig is promising for research of cancers.
    Besufetamig
  • HY-P991174
    Anti-TREM2 Antibody (AL2p-58) 98%
    Anti-TREM2 Antibody (AL2p-58) is a humanized IgG1 monoclonal antibody that targets TREM2. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).
    Anti-TREM2 Antibody (AL2p-58)
Cat. No. Product Name / Synonyms Application Reactivity